Get Clarity, Not Just Headlines.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Artificial Intelligence
Vladimir Putin
Social Media
Baseball
Trade
Education
India Economy
Golf
Senate
Donald Trump
European Union
Published • loading... • Updated

Redox Therapeutics Signs Exclusive License Agreement with The Curators of the University of Missouri to Create Filtration Technology to Address Healthcare and Environmental Needs

  • Redox Therapeutics signed an exclusive license agreement with The Curators of the University of Missouri for patented polymer nanoparticles technology aimed at endotoxin removal from various fluids such as water and plasma.
  • Redox Therapeutics is seeking partners in the healthcare and wastewater industries to implement this technology for effective sepsis treatment.
  • Sepsis is highlighted as a leading cause of death, with the World Health Organization stating that endotoxin significantly contributes to over 11 million fatalities annually.
  • The Association of American Medical Colleges notes that sepsis is the third leading cause of death in U.S. Hospitals.
Insights by Ground AI
Does this summary seem wrong?

12 Articles

All
Left
6
Center
2
Right
1
Hometown News LPHometown News LP
+10 Reposted by 10 other sources
Center

Redox Therapeutics Signs Exclusive License Agreement with The Curators of the University of Missouri to Create Filtration Technology to Address Healthcare and Environmental Needs

PHILADELPHIA, Pa., April 29, 2025 (SEND2PRESS NEWSWIRE) — Redox Therapeutics announces the signing of an exclusive license agreement with The Curators of the University of Missouri acting by and through the Missouri University of Science and Technology (Missouri S&T) for…

Read Full Article
Send2Press NewswireSend2Press Newswire

Redox Therapeutics Signs Exclusive License Agreement with The Curators of the University of Missouri to Create Filtration Technology to Address Healthcare and Environmental Needs - Send2Press Newswire

PHILADELPHIA, Pa., April 29, 2025 (SEND2PRESS NEWSWIRE) — Redox Therapeutics announces the signing of an exclusive license agreement with The Curators of the University of Missouri acting by and through the Missouri University of Science and Technology (Missouri S&T) for a patented polymer nanoparticles technology designed for endotoxin removal from fluids such as water, protein solutions and plasma. Currently, it’s seeking partners in the healt…

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Left
67% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Send2Press Newswire broke the news in United States on Tuesday, April 29, 2025.
Sources are mostly out of (0)

Similar News Topics

Rolla, Missouri

Rolla, Missouri

News
For You
SearchBlindspotLocal